THE 5-SECOND TRICK FOR MBL77

Not all clients with CLL call for therapy. Despite all latest developments, the iwCLL still suggests watchful observation for individuals with asymptomatic sickness.86 This recommendation is predicated on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).